- Home
- AREC vs PLRX Comparison
AREC vs PLRX Comparison
Compare AREC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREC
- PLRX
- Stock Information
- Founded
- AREC 2013
- PLRX 2015
- Country
- AREC United States
- PLRX United States
- Employees
- AREC N/A
- PLRX N/A
- Industry
- AREC Coal Mining
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- AREC Energy
- PLRX Health Care
- Exchange
- AREC Nasdaq
- PLRX Nasdaq
- Market Cap
- AREC 97.1M
- PLRX 103.7M
- IPO Year
- AREC 2019
- PLRX 2020
- Fundamental
- Price
- AREC $1.78
- PLRX $1.45
- Analyst Decision
- AREC Strong Buy
- PLRX Hold
- Analyst Count
- AREC 2
- PLRX 10
- Target Price
- AREC $4.00
- PLRX $3.93
- AVG Volume (30 Days)
- AREC 3.7M
- PLRX 1.0M
- Earning Date
- AREC 08-19-2025
- PLRX 08-07-2025
- Dividend Yield
- AREC N/A
- PLRX N/A
- EPS Growth
- AREC N/A
- PLRX N/A
- EPS
- AREC N/A
- PLRX N/A
- Revenue
- AREC $330,304.00
- PLRX N/A
- Revenue This Year
- AREC $25,437.66
- PLRX N/A
- Revenue Next Year
- AREC $156.28
- PLRX N/A
- P/E Ratio
- AREC N/A
- PLRX N/A
- Revenue Growth
- AREC N/A
- PLRX N/A
- 52 Week Low
- AREC $0.38
- PLRX $1.10
- 52 Week High
- AREC $1.95
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- AREC 63.67
- PLRX 43.13
- Support Level
- AREC $1.18
- PLRX $1.40
- Resistance Level
- AREC $1.53
- PLRX $1.65
- Average True Range (ATR)
- AREC 0.24
- PLRX 0.11
- MACD
- AREC -0.00
- PLRX -0.03
- Stochastic Oscillator
- AREC 79.01
- PLRX 15.49
About AREC American Resources Corporation
American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.